Effect of Hyaluronic Acid in Wrinkles Treatment

Evaluating the Safety and Efficacy of highly viscous 33mg/ml Hyaluronic Acid volumiting filler in the treatment of facial wrinkles

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180228038905N1

Enrollment

Registered

2018-03-19

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Wrinkles.

Interventions

Intervention group:The product we used in this study was Variofil with the concentration of 33 mg/ml Hyaluronic Acid , The intensity of Facial Wrinkles determined the usage dose , we injected single d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Facial Wrinkles

Exclusion criteria

Exclusion criteria: Use of other treatments in past 3 months Patients with Neuromuscular junction disorder Active Infection near the site of Injection Allergy or Hypersensitivity to Hyaluronic Acid

Design outcomes

Primary

Measure	Time frame
Score of Facial Wrinkles. Timepoint: Before injection , 6 & 12 months after injection. Method of measurement: Inspection.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSetareh Tehrani

Islamic Azad University

s_tehrani@iautmu.ac.ir+98 212206660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026